GBI Adds Automated Aseptic Fill-Finish For Drug Products
21 Nov 2024 //
PRESS RELEASE
GBI Bio Adds Automated Aseptic Fill-Finish Capabilities
21 Nov 2024 //
CONTRACTPHARMA
Revolutionizing IND Filing With Rapid Biopharma Analytics
25 Oct 2024 //
PRESS RELEASE
Scaling Drug Product Development From Lab To Commercial
17 Oct 2024 //
PRESS RELEASE
GBI Biomanufacturing And Allterum Collaborate On Therapeutic Antibody
07 Oct 2024 //
PR NEWSWIRE
DoE For Clone Selection To Meet Biosimilar Quality Standards
16 Sep 2024 //
PRESS RELEASE
Trends At BioProcess East: Boosting Bioprocess Efficiency
30 Aug 2024 //
PRESS RELEASE
Novel Conjugation Advances For RadioImmune Conjugates: Case Studies
24 Aug 2024 //
PRESS RELEASE
What Investment Trends Are Shaping The Pharmaceutical Industry`s Future?
26 Jun 2024 //
PRESS RELEASE
How Can Tech Providers Aid Pharma`s Transition To Digital Operations?
26 Jun 2024 //
PRESS RELEASE
Emerging Trends in Bioconjugation: What the Future Holds
26 Jun 2024 //
PRESS RELEASE
Expediting Radioimmune Conjugates For Phase 0 Proof-Of-Concept Studies
15 Mar 2024 //
PRESS RELEASE
How To Accelerate Product Development While Maintaining Quality Standards?
08 Mar 2024 //
PRESS RELEASE
GBI Secures Commercial Manufacturing Contract, Solidifying Leadership
09 Jan 2024 //
PR NEWSWIRE
The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023
05 Jan 2024 //
PRESS RELEASE
The Most Significant Regulatory Decision or Guidance on the Horizon for 2024
05 Jan 2024 //
PRESS RELEASE